Review the PDF of the fact sheet on medications for advanced melanoma with board-relevant material. This fact sheet provides a list of the current US Food and Drug Administration approved medications for treatment of metastatic melanoma, and describes their mechanism of action and any related cutaneous side effects.
After, test your knowledge by answering the 5 practice questions.
Practice Questions
1. Which of the following medications is considered an MEK inhibitor?
a. aldesleukin
b. dacarbazine
c. ipilimumab
d. recombinant interferon alfa-2b
e. trametinib
